Hanx Biopharmaceuticals Sets Out Board and Committee Structure
I'm PortAI, I can summarize articles.
Hanx Biopharmaceuticals (Wuhan) Co. Ltd. has announced its board composition, led by chairman Dr. Zhang Faming, including executive, non-executive, and independent non-executive directors. The company detailed its three key board committees—Audit, Nomination, and Remuneration—clarifying the roles of chairpersons and members, enhancing corporate governance and transparency for shareholders. Hanx Biopharmaceuticals is listed in Hong Kong under stock code 3378, focusing on biologic drugs and therapies, with a current market cap of HK$2.19B.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments